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Introduction 
Mother Nature has been considered both historically and statistically as the 
most prolific source of drugs in human medicine: the vast majority of drugs 
used today is natural products (NPs), NP derivatives or synthetic mimetics 
related to NPs. Nevertheless, over the past two decades, in parallel with the 
expansion of high-throughput screening (HTS) and large compound libraries 
prepared by parallel synthesis, the practice of NP-based drug discovery has 
been gradually de-emphasized by the pharmaceutical industry. This paradigm 
shift can be traced back to a number of scientific as well as economical 
reasons. However, one of the main reasons argued against the NP-based hit 
generation (i.e., screening mixtures), that it is difficult to harmonize with the 
modern HTS-based approach: sequential and iterative application of the 
bioassay, the separation (fractionation/isolation) and structure elucidation 
steps lead necessarily to an inherently slow workflow. Moreover, the process 
of bioactivity-guided fractionation is further burdened by the “re-isolation” of 
already known compounds (dereplication). 
The above outlined issues, however, could be efficiently tackled by 
the synergistic melding of the three crucial processes, resulting in a 
“coupled” (profiling) analytical approach, comprising the high resolution of 
the complex mixture, the reliable detection and correlation of the biological 
response to each constituent, and finally the rapid dereplication of the 
bioactives. Depending on the studied biological phenomenon (e.g., enzyme 
inhibition, receptor binding, free radical scavenging activity), and the type of 
coupling (e.g., at-line, off-line, on-line), a number of innovative methods 
with different terms have been implemented in drug discovery practice. It 
must be noted here, that the enormous development in separation technology 
and instrumental analysis, which took place in recent years, was essential to 
the birth of this area. Owing to the appearance of robust ion sources and 
ultra-efficient chromatographic stationary phases and instruments, the high-
performance liquid chromatography coupled to mass spectrometry (HPLC-
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MS) systems have opened a new dimension in the NP-mixture analysis both 
in terms of resolution and speed. In addition, the huge improvement in the 
sensitivity of nuclear magnetic resonance spectroscopy (NMR), and the 
expansion of the increasingly richer chemical and biological databases have 
also contributed significantly to more efficient dereplication processes.  
This PhD work is a contribution focusing on the implementation of 
the above discussed methodological approach in two distinctive, but 
therapeutically highly relevant NP research areas. First, to identify 
antioxidants in plant extracts, in vitro radical scavenging assays were coupled 
off-line to HPLC methods. Second, to narrow the gap between NP research 
and the demand of early stage central nervous system drug discovery, the 
applicability of the parallel artificial membrane permeability assay specific 
for the blood-brain barrier (PAMPA-BBB) to NPs and plant extracts was 
thoroughly studied.  
   
Objectives 
The primary aim of our work was to design, adopt and/or validate, and 
perform screenings of the plant extract library (N=4400) of Gedeon Richter 
Plc. The screening assays included a cytotoxicity, an antioxidant (2,2-
diphenyl-1-picrylhydrazyl radical, DPPH), and a blood-brain barrier 
permeability screening campaign. As the plant extract hits emerged from the 
latter two screenings proved to be complex mixtures of secondary plant 
metabolites, we attempted to couple the bioassays of particular screens to 
HPLC-based analytical procedures. While doing this, our motivation was to 
shorten the bioassay-guided isolation route of the active principle(s), 
particularly in the lead compound identification and dereplication step. 
Moreover, by mean of the presented case studies, we have endeavored to 
contribute to the phytochemical and pharmacological characterization of the 
investigated plant species. 
4 
 
The specific aims were the followings: 
1. To screen the plant extract library for cytotoxic activity and for 
antioxidant activity, and to analyze the dependence of these 
activities of plant extracts on the type (polarity) of the solvent 
extraction procedure. 
2.a.  To analyze and prioritize (dereplicate) the resulted non-cytotoxic 
and antioxidant plant extract hits by LC-MS, and to develop a LC-
MS method that can be coupled with the DPPH assay in order to 
effectively identify the radical scavenger constituents in one 
antioxidant plant extract hit, namely in the methanolic extract of 
Artemisia gmelinii. 
2.b.   To isolate and elucidate the chemical structure of the most active 
radical scavenger compounds in the methanolic extract of Artemisia 
gmelinii. 
3.a.   To adopt and validate the pyrogallol red bleaching test for HPLC in 
order to screen and characterize chemical constituents with 
peroxynitrite (ONOO
–
) scavenging activity in alcoholic extracts of 
Salvia species, since Salvia extracts proved to be predominant 
among the antioxidant hits. 
3.b.  To demonstrate the performance of the developed HPLC-based 
ONOO
–
 scavenging assay on the methanolic extract of Salvia 
miltiorrhiza Bunge. 
4.a.   To investigate the applicability of the PAMPA-BBB assay for NPs 
and plant metabolites, and to screen the plant extract library for NP 
compounds with high brain penetration propensity.   
4.b. To couple the PAMPA-BBB assay to NMR experiments and to 
demonstrate the feasibility of this type of coupling on BBB+ plant 
extract hits (exemplified by the extracts of Tanacetum parthenium, 
Vinca major, Salvia officinalis, and Corydalis cava).   
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Materials and Methods 
Plant material 
The plant extract library of Gedeon Richter Plc. was assembled mainly 
between 1999 and 2001, in the course of a contractual cooperation with 
major Institutes of Botany, Pharmacognosy and Medicinal Plant Research in 
Hungary (Vácrátót, Budapest, Szeged, Budakalász). This cooperation 
resulted in 4400 randomly collected individual extracts, originated from ca. 
500 drugs of 300 plant species endemic or to-grow in the Carpathian Basin. 
Based on the solvent extraction procedure, the apolar subset (N=1996) 
comprised extracts prepared with chloroform or in some case with petroleum 
ether, whereas samples originated from aqueous alcoholic extraction were 
considered as the polar subset (N=2404) of the library. 
Plant extracts used in detailed hit profiling case studies were the followings: 
 HPLC-based off-line DPPH scavenging: Artemisia gmelinii Webb. ex 
Stechm. (Asteraceae): aerial parts, Vácrátót, crude apolar (CHCl3-MeOH 
9:1) and polar extracts (70% MeOH), fractionated on silica gel. 
 HPLC-based off-line ONOO- scavenging: Salvia miltiorrhiza Bunge 
(Lamiaceae): herb, Vácrátót, crude polar extract (70% MeOH). 
 Blood-brain barrier permeability screening by PAMPA-BBB: 
Tanacetum parthenium (L.) Sch. Bip. (Asteraceae), aerial parts, 
Debrecen, cold CH2Cl2-MeOH (9:1); 
Corydalis cava Schweig. & Kört. (Papaveraceae), tubers, Dobogókő, 
prefractionated weakly basic alkaloid fraction; 
Salvia officinalis L. (Lamiaceae), leaves, Vácrátót, crude polar extracts 
(70% MeOH), fractionated on polyamide gel; 
Vinca major L. (Apocynaceae), aerial parts, Vácrátót, crude apolar 
(CHCl3-MeOH 9:1) and polar extracts (70% MeOH), fractionated on 
silica gel.  
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Instrumentation 
High performance liquid chromatography – mass spectrometry: All 
experiments were performed on an Agilent 1200 liquid chromatography 
system, coupled with an Agilent 6410 triple quadrupole mass spectrometer 
(QQQ-MS) equipped with an ESI source. MassHunter B.04.01 was used for 
data acquisition, and for qualitative and quantitative analysis. All analyses 
were carried out at 40 °C on an Ascentis Express C18 column (50 × 3.0 mm, 
2.7 µm) in optimized gradient elution modes. 
Nuclear magnetic resonance spectroscopy: All NMR measurements were 
performed on a Varian 800 MHz spectrometer equipped with a 
1
H{
13
C/
15
N} 
Triple Resonance 
13
C Enhanced Salt Tolerant Cold Probe operating at 800 
MHz for 
1
H and 201 MHz for 
13
C. All pulse sequences were taken from the 
VNMRJ-3.1 or 3.2 pulse sequence library without modification. 
Citotoxicity screening campaign 
Cytotoxicity screening of the full plant extract library was performed by the 
fluorescent measurement of resazurin reduction (Promega) on an 
immortalized chinese hamster ovarian (CHO) cell line. The assay is based on 
the ability of living cells to convert a redox dye (resazurin) into a fluorescent 
end product (resorufin). Plant extract plates were screened in a test 
concentration of 400 µg/mL with 1% DMSO present. Samples with activity 
above 20% were considered as cytotoxic. 
Antioxidant activity screening campaign 
The antioxidant activity screening of the full plant extract library was 
performed in microplate format according to the spectrophotometric DPPH 
method. Test samples were incubated with 60 µM ethanolic solution of 
DPPH for 30 min at RT. Screening concentration was set to the value of 66.7 
µg/mL. Plant extracts with activity above 80% were considered as primary 
hits. IC50 values of these hits were measured in a secondary experiment. 
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HPLC-based off-line DPPH scavenging assay 
The modified DPPH-spiking method of Tang et al. (2008) was applied to 
characterize the active constituents in the methanolic extract of A. gmelinii. 
Briefly, 0.5 mL of A. gmelinii methanolic extract dissolved in DMSO and 0.5 
mL of 1.5 mM DPPH stock solution were mixed and allowed to react for 30 
min. The reaction mixture was then filtered and analyzed with an optimized 
HPLC-MS method. Ethanol was added to the extract to provide the unreacted 
control sample. After comparing the chromatograms of the reaction mixture 
with the one of the control sample, the most active two compounds of the 
extract were isolated with targeted preparative HPLC and analyzed 
extensively by HRMS and NMR. 
HPLC-based off-line peroxynitrite scavenging assay 
The pyrogallol red bleaching test used for peroxynitrite (ONOO
-
) scavenging 
activity measurement was adopted for HPLC by an extensive analysis of a 
phenolic model mixture representative for alcoholic extracts of Salvia species 
(N=17, 600 µM for each). HPLC conditions, such as eluent pH (1.90), 
injection volume (6 µL) and detection wavelength (470 nm) were carefully 
optimized for the selective detection of the test substrate pyrogallol red. 
Degradation kinetics of phenolic compounds in mixture were assessed after 
the reaction with increasing concentration of ONOO
-
 (0.5-10 mM) and 
compared with individual scavenging activitites (IC50). Finally, the developed 
assay was demonstrated on the methanolic extract of S. miltiorrhiza. 
Blood-brain barrier permeability screening and related methods 
PAMPA-BBB experiments were performed according to standard a protocol: 
Millipore 96-well sandwich plate system, 0.01 M phosphate buffered saline 
(PBS) at pH 7.4 in the donor as well as in the acceptor phase, BBB-specific 
porcine brain lipid dissolved in n-dodecane, incubation at 37 °C for 4 hrs. 
Validation of the PAMPA-BBB assay was performed by the effective 
permeability (Pe, cm/s) measurement of a NP (N=23) and NP-like drugs (20) 
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test set. The non-cytotoxic subset of the plant extract library (N=1760) was 
screened with the same protocol in a test concentration of 1.0 mg/mL with 
10% DMSO as co-solvent in donor wells by an UV-vis reader (240-400 nm). 
In the case of the four BBB+ extracts studied (T. parthenium, C. cava, S. 
officinalis, V. major) PAMPA-BBB experiments were repeated in deutero 
PBS buffer, starting from the most concentrated samples (50 mg/mL) with 
10% co-solvent. The resulting acceptor solutions were collected and 1-1 mL 
from each sample was subjected directly to NMR analysis. 
Quantification of reference compounds, NP and NP-like drugs, and 
dereplication and characterization (by the chromatographic retention factor 
and MW) of BBB+ plant extracts (hits) were performed by optimized LC-MS 
methods. Co-solvent content (DMSO, MeOH) of PAMPA-BBB-derived 
acceptor solutions was quantified by gas chromatography-flame ionization 
detector.  
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Results and Discussion 
1. The cytotoxicity and the antioxidant screening of the plant extract library 
were successfully designed and performed. It was found that more than 
the half of the library (57%) possessed cytotoxic activity, whereas the 
percent of samples with considerable antioxidant activity was only 5.7%. 
Moreover, we demonstrated that both the cytotoxic and the antioxidant 
activity were significantly dependent on the type of the solvent 
extraction procedure: samples extracted with chloroform were twice as 
likely to show citotoxicity than samples originated from methanolic 
extraction, whereas radical scavenging activity was more pronounced 
among samples extracted with methanol. 
2.  Afterwards, in course of a case study, a DPPH-HPLC method was 
developed for the antioxidant-activity guided phytochemical 
investigation of a methanolic plant extract hit, namely Artemisia 
gmelinii.  
Novel methodological findings: It was demonstrated that the off-line 
coupling of the DPPH assay with the LC method enabled the rapid and 
reliable identification of the free radical scavenger molecules in the 
mixture. This proved to be a key advantage, since after the dereplication 
of 6 major constituents by LC-MS, the preparative HPLC purification 
was only targeted toward the isolation of the two most active compounds 
(3,5-O-dicaffeoylquinic acid and ethyl-3,5-O-dicaffeoylquinate). It must 
be noted, however, that the structure elucidation of the isolated 
dicaffeoylquinic acids (DCQAs) turned out to be an unexpectedly 
difficult task due to literature ambiguities. 
Novel phytochemical and pharmacological findings: Out of the eight 
identified compounds six, namely chlorogenic acid, 4-O-caffeoylquinic 
acid, luteolin-7-O-glucoside, apigenin-7-O-glucoside, and the two 
DCQAs were first described in A. gmelinii. Moreover, based on the high 
degree of phytochemical similitude with major hepatoprotective 
compounds of artichoke, it was speculated that the identified 
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phenylpropanoids and flavonoids may confirm by their antioxidant 
potential the ethnopharmacological usage of A. gmelinii in inflammatory 
liver conditions. 
3.  Next, the same off-line coupling concept was realized in the case of 
another radical species. The colorimetric pyrogallol red bleaching assay 
used for ONOO
–
 scavenging assessment was successfully adopted for 
HPLC. 
Novel methodological findings: We proved the theory by a thorough 
validation study that upon reaction with ONOO
–
, the peak areas of 
compounds in complex mixtures with radical scavenging potential will 
significantly and proportionally decrease or disappear in the 
chromatograms. Aspecific degradation of carnosol represented the 
inherent limitation of the assay. Thus, it was demonstrated that the 
developed assay enabled simultaneously and reliably the rapid chemical 
characterization and the ONOO
–
 scavenging activity profiling of 
alcoholic extracts of Salvia species. 
Novel phytochemical and pharmacological findings: By studying the 
ONOO
–
 scavenging activity of 17 phenoloid marker compounds of the 
genus Salvia, it was found that gallic acid, caffeic acid, rosmarinic acid, 
salvianolic acid B, quercetin, salvianolic acid A, and kaempferol 
possessed outstanding activity against ONOO
–
. Moreover, application of 
the developed assay on the methanolic extract of S. miltiorrhiza revealed 
that basically the phenylpropanoid constituents were responsible for the 
significant ONOO
–
 scavenging activity of this widely used medicinal 
herb. 
4.  In the second part of our work, to narrow the gap between NP research 
and the demand of early stage CNS drug discovery, applicability of the 
PAMPA-BBB assay to NPs and plant extracts was thoroughly 
demonstrated. 
Novel methodological findings: It was found that the PAMPA-BBB 
assay preserved its predictive power in the case of NPs and provided 
high phytochemical selectivity, which enabled its use as a unique 
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filtering tool in terms of selecting brain penetrable compounds from 
plant extracts. We took advantage of the single mechanism-based 
(passive diffusion) as well as the in vitro nature of the PAMPA-BBB 
assay: it was demonstrated that simple modifications in the assay design 
(i.e., performed in deuterated milieu with an elevated dose of 
multicomponent extracts) allowed the direct (at-line) use of PAMPA-
BBB filtered samples in a dereplication process, as performed by NMR 
and LC-MS. Finally, it was concluded that the developed PAMPA-
BBB/LC-MS/NMR cascade is worthy of being integrated in a HTS-
based, NP-utilizing CNS drug discovery environment.   
Novel phytochemical and pharmacological findings: By studying the 
effective BBB permeability profile of major phytochemical compound 
classes, it was revealed that, in accordance with basic concepts, 
glycosides and carboxylic acids were unable to pass across lipid bilayers 
by passive diffusion, whereas representative compounds of flavonoids 
(as aglycones), alkaloids, terpenes and coumarins showed moderate or 
considerable BBB permeability potential. Moreover, our work provided 
important in vitro evidences regarding the brain penetrability of the 
pharmacologically active constituents of T. parthenium, V. major, S. 
officinalis, and C. cava. 
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Conclusions 
Today’s drug discovery relies basically on the HTS-based approach and 
operates at an accelerated pace. To meet the demand of this industrial 
environment, innovative methods focusing on the improvement and 
acceleration of the NP-based lead generation have emerged and been 
implemented recently. Among those, HPLC-coupled assays used for both 
chemical and biological profiling of complex NP extracts have shown 
potential to significantly increase the efficiency of or even to fully substitute 
time-consuming bioactivity-guided fractionation procedures. The essence and 
simultaneously the greatest challenge in the development of such HPLC-
based profiling assays, beyond instrumentation issues, is the valid and 
efficient interfacing of biological data with chemo-analytical information.  
 Based on the resolution and multi-dimensional information content 
provided by the presented HPLC-based profiling assays, we conclude that the 
marriage of advanced separation and spectroscopic techniques to robust 
bioassays is a viable and powerful approach to NP-based lead generation. In 
addition, the developed profiling assays could be superior for the quality, 
efficacy and safety assessment of medicinal plant extracts and herbal 
formulas. Finally, we believe that these novel approaches will be gradually 
naturalized also in the mainstream drug discovery. 
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